Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.

Dumond JB, Yeh RF, Patterson KB, Corbett AH, Jung BH, Rezk NL, Bridges AS, Stewart PW, Cohen MS, Kashuba AD.

AIDS. 2007 Sep 12;21(14):1899-907.

2.

Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.

Else LJ, Taylor S, Back DJ, Khoo SH.

Antivir Ther. 2011;16(8):1149-67. doi: 10.3851/IMP1919. Review.

PMID:
22155899
3.

Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).

Else LJ, Taylor S, Back DJ, Khoo SH.

Antivir Ther. 2011;16(8):1139-47. doi: 10.3851/IMP1918. Review.

PMID:
22155898
4.

Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir.

Le Tiec C, Barrail A, Goujard C, Taburet AM.

Clin Pharmacokinet. 2005;44(10):1035-50. Review.

PMID:
16176117
5.

An update and review of antiretroviral therapy.

Piacenti FJ.

Pharmacotherapy. 2006 Aug;26(8):1111-33. Review.

PMID:
16863488
6.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
7.

Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.

Shey MS, Kongnyuy EJ, Alobwede SM, Wiysonge CS.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD005481. doi: 10.1002/14651858.CD005481.pub3. Review.

PMID:
23543540
8.

Pharmacokinetics of antiretrovirals in pregnant women.

Mirochnick M, Capparelli E.

Clin Pharmacokinet. 2004;43(15):1071-87. Review.

PMID:
15568888
9.

Combination antiretroviral studies for patients with primary biliary cirrhosis.

Lytvyak E, Montano-Loza AJ, Mason AL.

World J Gastroenterol. 2016 Jan 7;22(1):349-60. doi: 10.3748/wjg.v22.i1.349. Review.

10.

Pre-exposure prophylaxis for HIV infection: how antiretroviral pharmacology helps to monitor and improve adherence.

Blumenthal J, Haubrich R.

Expert Opin Pharmacother. 2013 Sep;14(13):1777-85. doi: 10.1517/14656566.2013.812072. Review.

11.

Initial therapy for human immunodeficiency virus: broadening the options.

Sension M.

HIV Clin Trials. 2004 Mar-Apr;5(2):99-111. Review.

PMID:
15116286
12.

Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies.

Waitt CJ, Garner P, Bonnett LJ, Khoo SH, Else LJ.

J Antimicrob Chemother. 2015 Jul;70(7):1928-41. doi: 10.1093/jac/dkv080. Review.

13.

Post-exposure prophylaxis guidelines for children and adolescents potentially exposed to HIV.

Bamford A, Tudor-Williams G, Foster C.

Arch Dis Child. 2017 Jan;102(1):78-83. doi: 10.1136/archdischild-2015-309297. Review.

PMID:
27974330
14.

Pharmacokinetics of antiretrovirals in mucosal tissue.

Cottrell ML, Srinivas N, Kashuba AD.

Expert Opin Drug Metab Toxicol. 2015 Jun;11(6):893-905. doi: 10.1517/17425255.2015.1027682. Review.

Items per page

Supplemental Content

Support Center